Repair Materials from Bacteria
Evonik's biocellic® Innovative Materials Support Gentler and More Efficient Skin Healing
Evonik's biocellic® brand offers an innovative solution for wound healing derived from bacterial fermentation. This unique material, known for its biocompatibility and skin tolerance, addresses critical challenges in wound care, particularly for burn injuries and chronic wounds.
Uwe Beekmann, a pharmacologist at Evonik, oversees the production of this specialized cellulose in a controlled fermentation environment. During this process, bacteria convert glucose into nanostructured cellulose fibers that create a soft, slippery dressing, promoting a moist and cooling environment for the wound. This feature significantly reduces pain and supports faster healing, especially in sensitive cases like burns, where traditional dressings can cause discomfort.
The image shows the strain that produces cellulose. After fermentation is complete, the gel-like substance is separated from the nutrient solution, and all bacteria are removed. The remaining cellulose and water can then be cut into any desired dressing shape.
The biocellic® material is distinguished by its finely woven internal structure, providing exceptional stability and strength while remaining free from the impurities commonly found in plant-based alternatives. This characteristic makes it an ideal candidate for a variety of medical applications, ensuring optimal moisture retention and absorption of exudates, which are crucial for effective wound management.
The biocellic® product range includes epicite® hydro, which provides continuous moisture and cooling for patients, and epicite® balance, designed specifically for chronic wounds with moderate exudate. Beyond acute care, these materials are also being explored for post-surgical treatment and cosmetic recovery, emphasizing their versatility.
Since Evonik's strategic acquisition of JeNaCell in 2021, the collaboration has accelerated the integration of bacterial cellulose technology into the global healthcare market. Evonik continues to innovate in this area, developing solutions that enhance patient comfort and treatment efficacy, ultimately representing the future of wound care.
With biocellic®, Evonik stands at the forefront of medical advancements, offering a new generation of gentle and effective treatment options that empower both patients and healthcare providers.